Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 128
News
News | 27 May 2022

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs

News
News | 27 May 2022

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania

The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential

News
News | 26 May 2022

Roche develops unique PCR tests to detect monkeypox virus

Roche and its subsidiary TIB Molbiol have developed three different LightMix Modular Virus kits for the detection of the virus

News
News | 26 May 2022

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E

News
News | 26 May 2022

Lumenis OptiLight wins 2022 MedTech Breakthrough Award

For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies

News
News | 26 May 2022

Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.

News
News | 25 May 2022

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA

News
News | 25 May 2022

Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData

According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029

News
News | 25 May 2022

Piramal Pharma Solutions upgrades Pithampur site

New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses

News
News | 25 May 2022

Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries

Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap

News
News | 25 May 2022

Max Healthcare Institute Q4 FY2022 consolidated PAT slips QoQ to Rs. 123.73 Cr

The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022

News
News | 25 May 2022

Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma

This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan

News
News | 25 May 2022

IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22

The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.

News
News | 24 May 2022

Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections

'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)

News
News | 24 May 2022

HNZ Lifesciences unveils its new brand Amio Wellness

The key categories include intimate wellness, skincare & hair care

News
News | 24 May 2022

NHA announces revamped ABHA mobile application

The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)

News
News | 23 May 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear

News
News | 23 May 2022

Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland

The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland

News
News | 22 May 2022

Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities

A total of five observations for Goa and 17 for Monroe

News
News | 22 May 2022

Karkinos Healthcare receives investment from Mayo Clinic

Investment with representation on the Board of Directors and technical know-how

Startup

Digitization